U.S. Online Retail and Ecommerce Stock News

Tesla (NasdaqGS:TSLA) and LG Energy Solution plan to build a new US battery cell plant in Michigan. The partners expect to invest about $4.3b in the facility to support Tesla’s energy storage products. The project is aimed at increasing US based battery capacity and reducing reliance on imported cells. Tesla, trading around $395.56, is moving further into energy storage with this new manufacturing partnership. The stock shows a 66.2% return over the past year and a 115.9% return over three...

Biogen announced that Chief Legal Officer Susan H. Alexander will depart at the end of May 2026. The company has begun a search for her successor to lead its legal and compliance functions. This change comes during an active period for Biogen's product pipeline and corporate activity. For investors tracking Biogen, ticker NasdaqGS:BIIB, this leadership update lands against a mixed share price record. The stock trades at $183.26, with a 1 year return of 27.7%, while the 3 year and 5 year...

If you are wondering whether Southern at US$99.11 offers fair value or whether you are paying a premium for stability, this article breaks down what that price really implies. The stock has returned 1.9% over the past week, 4.4% over the last 30 days, 13.7% year to date and 13.1% over the past year, with longer term returns of 60.8% over 3 years and 100.1% over 5 years that many investors will want to weigh against today’s valuation. Recent coverage of Southern has focused on its role in the...

Why SkyWater Technology Is Back On Investor Radars SkyWater Technology (SKYT) has drawn fresh interest after a year total return above 200%, with the stock last closing at US$27.86 and market cap around US$1.3b. Investors are weighing how recent share performance aligns with underlying fundamentals. See our latest analysis for SkyWater Technology. Short term, momentum has cooled a little with a 7 day share price return of 3.33% decline and 30 day share price return of 4.69% decline, but the...

Conference spotlight and shifting expectations BrightSpring Health Services (BTSG) moved further onto investors’ radar after its presentation at the Leerink Global Healthcare Conference, where management outlined efficiency efforts, specialty pharmacy growth plans, and responses to regulatory pressures. Those conference remarks, combined with recent analyst upgrades and higher earnings estimates, have fueled fresh debate about how BrightSpring’s mix of home based care and pharmacy solutions...

In early March 2026, Redwire Corporation announced it had been awarded a prime contract by Belgian Defence to develop and deliver MATTEO, Belgium’s first national security satellite, providing secure and independent space-based services for defence. This contract, alongside continued NASA funding for Redwire’s in-space pharmaceutical research platform on the International Space Station, highlights how its space infrastructure and microgravity technologies are being adopted by both defence...

Bitdeer Technologies Group recently launched its self-developed SEALMINER DL1 Air mining machine, optimized for the Scrypt algorithm and supporting Litecoin, Dogecoin, and other coins, while also reporting February 2026 operating results that showed large year-over-year increases in hash rate under management, mining rigs, and self-mined Bitcoin. The combination of a new, energy‑efficient Scrypt miner with flexible operating modes and sharply higher managed hash power highlights Bitdeer’s...

If you are wondering whether New Jersey Resources at around US$54.90 still offers value or is pricing in too much optimism, you are asking the right question before making any long term decisions. The stock has returned 0.3% over the last 7 days, 1.2% over 30 days, 19.4% year to date, 16.0% over 1 year, 17.4% over 3 years and 62.7% over 5 years, which puts the current share price in a different context than a simple snapshot. Recent attention on New Jersey Resources has centered on its role...

CytomX Therapeutics earnings and Varseta-M data come into focus CytomX Therapeutics (CTMX) is back on radar after reporting full year 2025 results alongside early Phase 1 expansion data for its EpCAM-targeting ADC, Varseta-M, in late-line metastatic colorectal cancer. See our latest analysis for CytomX Therapeutics. The recent Varseta-M data, full year 2025 results and a new shelf registration plus follow-on equity filing have coincided with sharp share price momentum, with a 1 day share...

Earlier this month, Citcon announced a collaboration with Visa Direct to extend push-payment capabilities for cards, accounts, and wallets across select U.S. domestic and cross-border markets, while Visa also expanded its stablecoin-backed card issuance with Bridge and added a new Strategy and Business Development director, Skand Swarup. Together, these moves highlight Visa’s push to link traditional card networks with onchain settlement, broaden real-time payout options for merchants, and...

Earlier this month, Williams Trading upgraded Crocs from “Sell” to “Hold,” highlighting the footwear company’s current valuation, margin outlook, and potential relief from tariffs. The shift in analyst stance underscores how concerns about fashion trends and revenue pressures are being weighed against Crocs’ strong free cash flow and operating profitability. Now we’ll explore how this analyst upgrade, driven by valuation and tariff considerations, may influence Crocs’ broader investment...

Earlier this month, V.F. Corporation presented at Citi’s 2026 Global Consumer & Retail Conference in Aventura, Florida, outlining its latest business updates to investors and industry participants. The event comes amid scrutiny of VF Corp’s shrinking constant-currency revenue, pressured free cash flow margins, and declining return on invested capital, which together highlight ongoing operational headwinds. Next, we’ll examine how these signs of weakening demand and lower returns on invested...

Everpure (NYSE:PSTG) has launched Evergreen//One for FlashBlade//EXA, aimed at simplifying high performance data infrastructure for AI workloads. The company is preparing to roll out Everpure Data Stream in beta for enterprise AI, with a focus on automated data orchestration. New industry benchmark results showcase performance metrics for the platform in NVIDIA aligned AI architectures. Everpure, trading at $62.85, is putting fresh attention on AI focused data infrastructure with these...

R2 launch details and what they mean for Rivian stock Rivian Automotive (RIVN) has put firm numbers around its next growth pillar, laying out full trims, pricing and timing for the new R2 mid-size SUV, with first deliveries targeted for spring 2026. The R2 line slots below the existing R1 models in size and price, which matters if you are tracking how Rivian plans to reach a broader mainstream buyer while still supporting its premium brand positioning. See our latest analysis for Rivian...

Earlier this quarter, Emerson Electric reported first-quarter 2026 results that exceeded earnings expectations, lifted its full-year outlook, and unveiled a US$250 million share repurchase plan as part of a broader goal to return US$10.00 billion to shareholders by 2028. Management’s emphasis on electrification, energy security, and integrating artificial intelligence into its software portfolio suggests a sharpening focus on higher-value automation and digital solutions that could influence...

Recent performance snapshot Tenable Holdings (TENB) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months and year. At a last close of US$20.10, Tenable sits against a backdrop of annual revenue of US$999.4m and a reported net loss of US$36.1m, which keeps profitability and growth quality in focus for investors. See our latest analysis for Tenable Holdings. The recent 7 day share price return...

In recent weeks, Sandisk reported very large year-on-year net income growth, guided for sharply higher third-quarter revenues, and outlined multi‑year NAND supply agreements with data center customers amid intense AI infrastructure demand and tight industry capacity. This combination of strong current results, longer-term contract visibility through 2028, and AI-focused product investments positions Sandisk as a core supplier to hyperscalers reshaping data storage architectures. We’ll now...

Adobe and NVIDIA have entered a broad partnership to accelerate agentic AI and content creation workflows across Adobe’s marketing and creative platforms. The collaboration includes joint development of next generation Adobe Firefly AI models, integration of NVIDIA’s computing and open source agentic AI architectures, and new 3D digital twin solutions for enterprises. This agreement is positioned to influence Adobe’s product roadmap, AI capabilities, and appeal to both creative professionals...

Iron Mountain (NYSE:IRM) has agreed to acquire ACT Logistics in Australia as part of its global expansion. The company continues to grow its data center segment, adding to its traditional records management operations. Iron Mountain recently raised its dividend by 10%, highlighting its focus on shareholder returns. Iron Mountain, best known for records storage and information management, is in the middle of a meaningful shift in where its business is growing. The ACT Logistics deal broadens...

Investors may be wondering whether USA Rare Earth's current share price reflects its true worth, or if the market is missing something important. The stock last closed at US$19.49, with returns of 4.2% over 7 days, 0.5% over 30 days, 37.7% year to date and 37.9% over the past year, which may catch the eye of investors watching for changing expectations or risk perceptions. Recent news coverage has centered on USA Rare Earth's position in the materials sector and the broader interest in rare...

In February 2026, Arrowhead Pharmaceuticals received US FDA approval for its first drug, REDEMPLO (plozasiran), for familial chylomicronemia syndrome, with additional regulatory clearances in China and Canada and an early US launch supported by over 100 initial prescriptions and a dedicated patient support program. This approval shifts Arrowhead from a purely R&D-focused biotech to a commercial-stage company, potentially reshaping how investors view its revenue mix, risk profile, and...

Event context and recent share performance Commerce Bancshares (CBSH) has come onto investors’ radar after a recent price move that left the stock about 10% lower over the past month and roughly 9% lower over the past 3 months. This pullback sits against a backdrop of US$1,711.7m in revenue, US$560.9m in net income, and a market value of about US$7b. This has prompted fresh questions about how the bank’s current valuation lines up with its fundamentals. See our latest analysis for Commerce...

That combination of strong long term returns and recent share price weakness often raises a simple question for investors: is Teekay Tankers still offering value at today's price? Before looking at detailed valuation models, it helps to recap what has been happening with the share price and the business itself. Over the last year, the stock has returned 77.0%, while year to date it is up 28.5%. In the last 7 days and 30 days, however, the share price has slipped 11.0% and 6.2% respectively,...

Investors may be wondering whether Ocugen at around US$2.33 is still interesting after a big run, or if the recent excitement has already been priced in. The stock has posted returns of 40.4% over 7 days, 65.2% over 30 days, 68.8% year to date and 306.9% over the past year, while the 3 year return sits at 146.3% and the 5 year return at a 72.7% decline. Recent headlines around Ocugen have focused on its position in the biotech space and evolving expectations for its pipeline and...